L. Orlandi et al., EFFECT OF MELPHALAN AND HYPERTHERMIA ON P34(CDC2) KINASE-ACTIVITY IN HUMAN-MELANOMA CELLS, British Journal of Cancer, 74(12), 1996, pp. 1924-1928
We previously reported that combined treatment with melphalan and mild
hyperthermia (1 h at 42 degrees C) caused a synergistic cytotoxic eff
ect in JR8 melanoma cells, paralleled by a stabilisation of melphalan-
induced G(2)-phase cell block. In this study, we investigated the effe
ct of melphalan and hyperthermia on proteins that regulate G(2)-M tran
sition. Neither hyperthermia nor melphalan at a concentration of 2.5 m
u g ml(-1), which had no antiproliferative effect at 37 degrees C, int
erfered with cyclin B-1 expression or p34(cdc2) kinase activity. At a
concentration of 8.5 mu g ml(-1), which reduced cell growth by 50% at
37 degrees C, melphalan inhibited p34(cdc2) kinase activity as a conse
quence of an increased tyrosine phosphorylation of the protein. A simi
lar inhibitory effect on p34(cdc2) kinase was obtained when the lowest
melphalan concentration (2.5 mu g ml(-1)) was used under hyperthermic
conditions. Our results indicate that thermal enhancement of melphala
n cytotoxicity could be mediated at least in part by an inhibition of
p34(cdc2) kinase activity, which prevents cell progression into mitosi
s.